Tuesday, May 30, 2023


Biotechnology News Magazine


Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

Under the terms of Pharming's 2019 exclusive license agreement with Novartis for leniolisib, the corresponding first commercial sale of Joenja® triggers a $10 million milestone payment by Pharming to Novartis.

MGCLF – MGC Pharma’s CannEpil® Now Accessible to UK Patients on Named Patient Request Basis

European pharmaceutical company offers its investigational medicinal product to a wide range of specialist medical practitioners in the United Kingdom Epidiolex's Success Highlights Potential for MGC Pharma's CannEpil®.

Nirsevimab: Sanofi AstraZeneca and Sobi simplify contractual agreements

Sanofi has simplified its contractual arrangements relating to the development and commercialization of Beyfortus (nirsevimab) in the United States (U.S.). Under the new and updated...

Risk From Pharma Reps Using Unapproved Content and Messaging in the Field Persists, but a Focus on Training Could Be the Answer

ACTO advises Study Reveals 50% of respondents in leadership roles catch incidents of field reps using unapproved content, but a continuous learning culture could eliminate this behavior.

Galmed Announces Issuance of New Composition of Matter Patent for Aramchol meglumine Salt

Galmed expands foundational patent protection for Galmed's innovative first-in- class drug Aramchol through the end of 2034

Generian Achieves First Milestones in Mitobridge Collaboration

Hank Safferstein, PhD, JD, Chief Executive Officer of Generian said, "These hit series represent first-in-class compounds that directly bind to transcription factors for degradation or stabilization."